Flotte TR - Search Results

1

Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndrome.

Keeler AM, Flotte TR. Keeler AM, et al. Among authors: flotte tr. Hum Gene Ther. 2012 Jun;23(6):548-56. doi: 10.1089/hum.2012.087. Hum Gene Ther. 2012. PMID: 22642257 Free PMC article. Review.

2

A fluorescence video-endoscopy technique for detection of gene transfer and expression.

Flotte TR, Beck SE, Chesnut K, Potter M, Poirier A, Zolotukhin S. Flotte TR, et al. Gene Ther. 1998 Feb;5(2):166-73. doi: 10.1038/sj.gt.3300579. Gene Ther. 1998. PMID: 9578835

3

Recombinant adeno-associated virus vector-based gene transfer for defects in oxidative metabolism.

Owen R IV, Lewin AP, Peel A, Wang J, Guy J, Hauswirth WW, Stacpoole PW, Flotte TR. Owen R IV, et al. Among authors: flotte tr. Hum Gene Ther. 2000 Oct 10;11(15):2067-78. doi: 10.1089/104303400750001381. Hum Gene Ther. 2000. PMID: 11044909

4

Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients.

Virella-Lowell I, Poirier A, Chesnut KA, Brantly M, Flotte TR. Virella-Lowell I, et al. Among authors: flotte tr. Gene Ther. 2000 Oct;7(20):1783-9. doi: 10.1038/sj.gt.3301268. Gene Ther. 2000. PMID: 11083501

5

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB. Flotte TR, et al. Hum Gene Ther. 2003 Jul 20;14(11):1079-88. doi: 10.1089/104303403322124792. Hum Gene Ther. 2003. PMID: 12885347 Clinical Trial.

6

Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults.

Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, Humphries M. Flotte TR, et al. Hum Gene Ther. 2004 Jan;15(1):93-128. doi: 10.1089/10430340460732490. Hum Gene Ther. 2004. PMID: 14965381 Clinical Trial.

7

Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors.

Flotte TR. Flotte TR. Gene Ther. 2004 May;11(10):805-10. doi: 10.1038/sj.gt.3302233. Gene Ther. 2004. PMID: 15042119 Review. No abstract available.

8

Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective.

Flotte TR. Flotte TR. Hum Gene Ther. 2004 Jul;15(7):716-7. doi: 10.1089/1043034041361190. Hum Gene Ther. 2004. PMID: 15242531 No abstract available.

9

Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.

Sirninger J, Muller C, Braag S, Tang Q, Yue H, Detrisac C, Ferkol T, Guggino WB, Flotte TR. Sirninger J, et al. Among authors: flotte tr. Hum Gene Ther. 2004 Sep;15(9):832-41. doi: 10.1089/hum.2004.15.832. Hum Gene Ther. 2004. PMID: 15353038

10

Enhancing rAAV vector expression in the lung.

Virella-Lowell I, Zusman B, Foust K, Loiler S, Conlon T, Song S, Chesnut KA, Ferkol T, Flotte TR. Virella-Lowell I, et al. Among authors: flotte tr. J Gene Med. 2005 Jul;7(7):842-50. doi: 10.1002/jgm.759. J Gene Med. 2005. PMID: 15838934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters